There is no evidence that norfloxacin has any teratogenic effect. Restraint in the use of norfloxacin during pregnancy is recommended as a matter of principle, rather than because of demonstrated fetotoxicity. Tinidazole readily crosses the placenta and is distributed into breast milk. Tinidazole should not be given during the 1st trimester of pregnancy and is not recommended in lactation.